Axsome Therapeutics, Inc. (AXSM) Cash Flow Quarterly - Discounting Cash Flows
AXSM
Axsome Therapeutics, Inc.
AXSM (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2025 (Q4)
12-31
2025 (Q3)
09-30
2025 (Q2)
06-30
2025 (Q1)
03-31
2024 (Q4)
12-31
2024 (Q3)
09-30
2024 (Q2)
06-30
2024 (Q1)
03-31
2023 (Q4)
12-31
2023 (Q3)
09-30
2023 (Q2)
06-30
2023 (Q1)
03-31
2022 (Q4)
12-31
2022 (Q3)
09-30
2022 (Q2)
06-30
2022 (Q1)
03-31
2021 (Q4)
12-31
2021 (Q3)
09-30
2021 (Q2)
06-30
2021 (Q1)
03-31
2020 (Q4)
12-31
2020 (Q3)
09-30
2020 (Q2)
06-30
2020 (Q1)
03-31
2019 (Q4)
12-31
2019 (Q3)
09-30
2019 (Q2)
06-30
2019 (Q1)
03-31
2018 (Q4)
12-31
2018 (Q3)
09-30
2018 (Q2)
06-30
2018 (Q1)
03-31
2017 (Q4)
12-31
2017 (Q3)
09-30
2017 (Q2)
06-30
2017 (Q1)
03-31
2016 (Q4)
12-31
2016 (Q3)
09-30
2016 (Q2)
06-30
2016 (Q1)
03-31
2015 (Q4)
12-31
2015 (Q3)
09-30
2015 (Q2)
06-30
2015 (Q1)
03-31
2014 (Q4)
12-31
2014 (Q3)
09-30
2014 (Q2)
06-30
2014 (Q1)
03-31
Report Filing: 2026-02-23 2026-02-23 2025-11-03 2025-08-04 2025-05-05 2025-02-18 2024-11-12
1234
Net Income/Starting Line -183.2 -28.56 -47.23 -47.97 -59.41 -74.91 -64.6
1234
Cash From Operating Activities -93.41 -18.65 1.05 -32.42 -43.38 -26.2 -18.63
1234
Depreciation and Amortization 8.12 2.27 2.41 1.71 1.72 2.07 2.06
1234
Deferred Income Tax 0 0 0 0 0 0 0
1234
Stock Based Compensation 71.02 0 23.1 24.61 23.31 21.99 21.66
1234
Other Non-Cash Items 33.69 14.99 13.98 3.56 1.16 11.85 38.32
1234
Changes in Working Capital -23.06 -7.36 8.78 -14.33 -10.15 12.8 -16.07
1234
Accounts Receivable -82.46 -27.96 2.32 -37.43 -19.4 -17.91 -3.75
1234
Inventory -10.66 -3.64 -4.99 -1.78 -0.249 -4.14 1.29
1234
Accounts Payable -6.46 11.31 -37.4 5.97 13.66 7.74 2.91
1234
Deferred Revenue 76.53 12.93 48.86 18.91 -4.17 27.1 -16.52
1234
Other Working Capital 0 0 0 0 0 0 0
1234
Cash From Investing Activities -0.48 -0.071 -0.058 -0.013 -0.338 -0.03 -0.09
1234
Investments in Property Plant and Equipment -0.48 -0.071 -0.058 -0.013 -0.338 -0.03 0.15
1234
Payments for Acquisitions 0 0 0 0 0 0 0
1234
Purchases of Securities 0 0 0 0 0 0 0
1234
Sales and Maturities of Investments 0 0 0 0 0 0 0
1234
Other Investing Activities 0 0 0 0 0 0 -0.24
1234
Cash From Financing Activities 101.5 16.39 21.27 34.54 29.27 14.24 30.41
1234
Debt Repayment -7.75 -0.541 -0.664 -6.14 -0.401 -0.33 -0.311
1234
Common Stock Issued 109.6 20.91 25.28 43.78 19.65 16.42 13.1
1234
Common Stock Repurchased 0 0 0 0 0 0 0
1234
Dividends Paid 0 0 0 0 0 0 0
1234
Other Financing Activities -0.408 -3.99 -3.35 -3.09 10.02 -1.84 17.61
1234
Effect of Forex Changes on Cash 0 0 0 0 0 0 0
1234
Net Change in Cash 22.02 -2.34 22.26 2.11 -14.44 -11.99 11.68
1234
Cash at Beginning of Period 300.9 325.3 303 300.9 315.4 327.3 315.7
1234
Cash at End of Period 322.9 322.9 325.3 303 300.9 315.4 327.3
1234
Free Cash Flow -93.81 -19 0.988 -32.42 -43.38 -26.23 -18.48
1234
Operating Cash Flow -93.41 -18.65 1.05 -32.42 -43.38 -26.2 -18.63
1234
Capital Expenditure -0.409 -0.351 -0.058 0 0 -0.03 0.15
1234
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program